2003•Humana Press eBooksRequires access

Crystallization and Crystal Structure Determination of Ribonuclease A-Ribonuclease Inhibitor Protein Complex

Boštjan Kobe

Open publisher page 6 citations

Abstract

Ribonuclease inhibitor (RI) is a cytoplasmic protein of ∼50 kDa that tightly binds and inhibits ribonucleases (RNases) from the pancreatic superfamily (). Diverse RNases with very limited sequence similarities, including RNase A, angiogenin, RNase-2 (also known as eosinophil-derived neurotoxin (EDN) or placental RNase), and RNase-4 are inhibited with K i values between 10−14 and 10−16 M. These affinities are among the highest reported for noncovalent binding of proteins. The binding occurs with 1∶1 stoichiometry. A subset of the pancreatic ribonuclease superfamily, including the amphibian ribonucleases such as frog-liver ribonuclease, sialic acid-binding lectin, and P-30 protein, are not inhibited by RI. The potent inhibitory activity of RI is believed to be utilized in RNA processing, angiogenesis, and protection of the cell from toxic ribonucleases.

About this research paper

What this paper is about

Ribonuclease inhibitor (RI) is a cytoplasmic protein of ∼50 kDa that tightly binds and inhibits ribonucleases (RNases) from the pancreatic superfamily (). Diverse RNases with very limited sequence similarities, including RNase A, angiogenin, RNase-2 (also known as eosinophil-derived neurotoxin (EDN) or placental RNase), and RNase-4 are inhibited with K i values between 10−14 and 10−16 M. These affinities are among the highest reported for noncovalent binding of proteins. The binding occurs with 1∶1 stoichiometry. A subset of the pancreatic ribonuclease superfamily, including the amphibian ribonucleases such as frog-liver ribonuclease, sialic acid-binding lectin, and P-30 protein, are not inhibited by RI. The potent inhibitory activity of RI is believed to be utilized in RNA processing, angiogenesis, and protection of the cell from toxic ribonucleases.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ribonuclease inhibitor (RI) is a cytoplasmic protein of ∼50 kDa that tightly binds and inhibits ribonucleases (RNases) from the pancreatic superfamily (). Diverse RNases with very limited sequence similarities, including RNase A, angiogenin, RNase-2 (also known as eosinophil-derived neurotoxin (EDN) or placental RNase), and RNase-4 are inhibited with K i values between 10−14 and 10−16 M. These affinities are among the highest reported for noncovalent binding of proteins. The binding occurs with 1∶1 stoichiometry. A subset of the pancreatic ribonuclease superfamily, including the amphibian ribonucleases such as frog-liver ribonuclease, sialic acid-binding lectin, and P-30 protein, are not inhibited by RI. The potent inhibitory activity of RI is believed to be utilized in RNA processing, angiogenesis, and protection of the cell from toxic ribonucleases.

Key concepts: Angiogenin, Pancreatic ribonuclease, Ribonuclease, RNase P, Ribonuclease III, Biology, Biochemistry, Bovine pancreatic ribonuclease

Related papers

Back to paper searchBrowse research topicsOriginal source
Crystallization and Crystal Structure Determination of Ribonuclease A-Ribonuclease Inhibitor Protein Complex — Research Paper | ScholarLens